Safety Evaluation of IV Tc 99m Tilmanocept and Comparison of Imaging With Sulfur Colloid in Subjects With and Without NASH
Clinical trial NCT03332940 · TERMINATED
Trial details
- NCT number
- NCT03332940
- Sponsor
- Navidea Biopharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-06
- Primary completion
- 2019-03-10
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.